Emer MacSweeney is a world-renowned expert in brain and mind health, including the diagnosis and treatment of Alzheimer's disease, chronic traumatic encephalopathy (CTE), and other neurodegenerative conditions. She is the cofounder, CEO, and medical director of Re:Cognition Health, which provides a specialist service for the accurate diagnosis and treatment of progressive neurodegenerative and neurodevelopmental conditions, as well as traumatic brain injury, with centers across the United States and the United Kingdom.
A pioneer in Alzheimer's research and treatment, Dr. MacSweeney has been involved in clinical trials since the early development of therapies for the disease and was the first clinician in Europe to administer the amyloid-targeting therapy Kisunla outside of a clinical trial. She trained in neuroradiology at The Hospital of Neurology and Neurosurgery, Queen Square, London, specializing in interventional vascular neuroradiology, and spent time on scholarship at Harvard University. Her TEDx talk on CTE and contact sports has been viewed more than five million times worldwide.
For decades, an Alzheimer’s disease diagnosis has been viewed as simply a confirmation of a disease, not an opportunity for treatment. Typically, patients or family members would notice subtle changes in memory. Once these symptoms reached the point where concern was raised to a physician, and referrals were made, often leading to months of waiting to see a neurologist, opportunities for even symptomatic treatment were significantly smaller. This diagnosis-to-treatment gap …
Read more…
Early Alzheimer’s detection is now a treatment decision
